Genencor forecasts 17% margin without BioIsoprene

ERJ staff report (DS)

Copenhagen -- Gene technology company Danisco said its Genencor subsidiary will achieve growth greater than 7 percent in the coming financial year, and report a EBIT margin above 17 percent.

Genencor is working with Goodyear to produce a biologically-sourced production path for isoprene monomer, which could in time replace oil-derived isoprene monomers.

Genencor said its figures published last week, do not have any impact from the BioIsoprene project.

This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.

Press release from Danisco